Australia - English - Department of Health (Therapeutic Goods Administration)

point of care diagnostics australia pty ltd - ct889 - multiple clinical chemistry constituent ivds - the quantification of multiple clinical chemistry analytes in human whole blood, serum or plasma specimens.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nippon soda co., ltd - acetamiprid; n-methylpyrrolidone; dimethyl sulfoxide - soluble concentrate - acetamiprid pyridine active 225.0 g/l; n-methylpyrrolidone solvent other 334.0 g/l; dimethyl sulfoxide solvent other 515.0 g/l - insecticide - cotton | potato - cotton aphid | green mirid bug | green peach aphid | melon aphid

United States - English - NLM (National Library of Medicine)

yaopharma co., ltd. - venlafaxine hydrochloride (unii: 7d7rx5a8mo) (venlafaxine - unii:grz5rcb1qg) - venlafaxine 25 mg - venlafaxine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of venlafaxine tablets, usp in the treatment of major depressive disorder was established in 6-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii or dsm-iii-r category of major depression and in a 4-week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see clinical trials). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least four of the following eight symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - codeine phosphate hemihydrate, quantity: 8 mg; paracetamol, quantity: 500 mg - tablet, uncoated - excipient ingredients: soluble maize starch; povidone; microcrystalline cellulose; stearic acid; potassium sorbate; magnesium stearate; maize starch; purified talc - for the relief of acute moderate pain

United States - English - NLM (National Library of Medicine)

taizhou xinzhixuan daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - to decrease bacteria on the skin that could cause disease. - recommended for repeated use

United States - English - NLM (National Library of Medicine)

taizhou xinzhixuan daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - to decrease bacteria on the skin that could cause disease. - recommended for repeated use

United States - English - NLM (National Library of Medicine)

taizhou xinzhixuan daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - to decrease bacteria on the skin that could cause disease. - recommended for repeated use

United States - English - NLM (National Library of Medicine)

taizhou xinzhixuan daily-use co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - to decrease bacteria on the skin that could cause disease. - recommended for repeated use

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - paricalcitol - capsules soft - paricalcitol 1 mcg - paricalcitol - zemplar is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal insufficiency (chronic kidney disease stage 3 and 4 ) patients and chronic renal failure (chronic kidney disease stage 5) patients on haemodialysis or peritoneal dialysis.

European Union - English - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - chicken - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.